About Sense Diagnostics
Sense Diagnostics is a private company based in Cincinnati, Ohio. It has reported $4,740,870 raised in three offerings on Form D since September 2019. Its chief executive is Geoff Klass.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2023 | Nov 29, 2023 | $1,065,000of $4.0M target | 23 | $46,304 | EquityRule 506(b) | Form D ↗ |
| Oct 8, 2020 | Nov 2, 2020amended Mar 15, 2021 | $1,405,001of $1.5M target | 18 | $78,056 | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 30, 2019 | Sep 30, 2019 | $2,270,869of $5.1M target | 24 | $94,620 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $4,740,870 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sense Diagnostics's Form D filed Nov 29, 2023.
PG
Paul Gaitan
Executive officer
OA
Opeolu Adeoye
Director
GK
Geoff Klass
Chief Executive Officer and director
CW
Carol Warner
Director
JK
John Kraeutler
Director
DG
Daniel Geeding
Director
Earlier filings also listed Sally Kay (director, last listed Mar 2021), Roger Edwards (executive officer and director, last listed Mar 2021), Daniel Kincaid (executive officer and director, last listed Mar 2021), Roy Kulick (director, last listed Sep 2019) and Opeoluo Adeoye (director, last listed Sep 2019).